Why the study?
Dysregulation of the angiopoietin-Tie signaling pathway is linked to vascular impairments across multiple diseases, including cardiovascular diseases, but quantitative understanding of its mechanistic aspects and regulation remains needed.
A computational model of the angiopoietin-Tie pathway predicts that inhibiting VE-PTP, Tie1, and Tie2 cleavage synergistically enhances Tie2's vascular protective actions.
Model predictions of Tie2 synergy are hypothesis-generating; clinical translation in vascular disease remains untested.
The angiopoietin-Tie signaling pathway is an important vascular signaling pathway involved in angiogenesis, vascular stability, and quiescence. Dysregulation in the pathway is linked to the impairments in vascular function associated with many diseases, including cancer, ocular diseases, systemic inflammation, and cardiovascular diseases. The present study uses a computational signaling pathway model validated against experimental data to quantitatively study various mechanistic aspects of the angiopoietin-Tie signaling pathway, including receptor activation, trafficking, turnover, and molecular mechanisms of its regulation. The model provides mechanistic insights into the controversial role of Ang2 and its regulators vascular endothelial protein tyrosine phosphatase (VE-PTP) and Tie1 and predicts synergistic effects of inhibition of VE-PTP, Tie1, and Tie2 cleavage on enhancing the vascular protective actions of Tie2.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2019) studied Vascular signaling (Angiopoietin-Tie pathway). In silico perturbations (inhibition of VE-PTP, Tie1, and Tie2 cleavage) vs. Baseline simulation was evaluated on Maximum phosphorylated Tie2 at 30 min post-stimulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: